Emerging Cancer
1450 views
Rate Now: 1 2 3 4

average rating: 4.00 / 1 ratings
Created by investor1990
DESCRIPTION:

Date updated:05-17-2007

Okay, so I got hit bad by Dendreon, but who didn't? It was worth it to take a chance, especially after the surprisingly positive AC recommendation. But hindsight is 20/20, and I was blinded by message board contributors who didn't see the writing on the wall that pointed towards an approvable letter. But all is not lost if you are a true DNDN long as I still believe that the therapy has potential, and the experience has opened me up to the emerging cancer field, which even has it's own index fund in HHJ. This portfolio keeps track of all the stocks in this field, hopefully separating the wheat from the chaff.

symbol name last price % change open
  • +
  • ADLR
    Adolor Corp
  • $3.06
  • +0.33%
  • $3.00

No Analysis added

People owning ADLR also tend to own: AMGNGRPLMCNVECOXYTHORTWX

TheStreet.com Rating: D What is this?

  • +
  • AEZS
    Aeterna Zentaris
  • $0.92
  • 0.00%
  • $0.91

Adam Feuerstein answers questions about Genitope, Immunogen, and Nymox in his Biotech-Stock mailbag (http://www.thestreet.com/_tscs/newsanalysis/biotech/10354735.html). This is the only reason I added these stocks to this portfolio. Mainly to track to see if he is right. A reader asked if Genitope is the next Dendreon. Feuerstein thinks not, but sees competition with Genetech's non-Hodgkin's lymphoma drug. He doesn't see much hope for Immunogen either. And he doesn't like Nymox, instead recommending Spectrum and Aeterna Zentaris. So these stocks go into the Favorite column, and the others into Least Favorite. We'll see where they are in 6 months.

People owning AEZS also tend to own: ACLATHRATNIBBBYCAJCYNOKALU

TheStreet.com Rating: D What is this?

  • +
  • AGEN
    Antigenics Inc
  • $1.76
  • +0.57%
  • $1.74

No Analysis added

People owning AGEN also tend to own: ALXNATHRAVBCATFCXHALJCG

TheStreet.com Rating: D- What is this?

  • +
  • ARRY
    Array Biopharma I
  • $6.59
  • -0.90%
  • $6.62

No Analysis added

People owning ARRY also tend to own: AMMDBVFCAHCBSTCELGCICMX

TheStreet.com Rating: D What is this?

  • +
  • BDSI
    Biodelivery Sci I
  • $3.60
  • +0.56%
  • $3.65

No Analysis added

People owning BDSI also tend to own: DEOHALMONYXNFLXQSIRI

TheStreet.com Rating: E What is this?

  • +
  • BUF
    Minrad Intl Inc
  • $1.42
  • -3.40%
  • $1.55

No Analysis added

People owning BUF also tend to own: GOOGMSABVCLRTELRNGSITU

TheStreet.com Rating: D- What is this?

  • +
  • CEGE
    Cell Genesys Inc
  • $0.75
  • -2.60%
  • $0.78

Mentioned on the yahoo message boards. People noticed how it tracked DNDN back when that stock was running. Need more info, though.

People owning CEGE also tend to own: CAMPELNKFCELIDIXJBLUTALKTIE

TheStreet.com Rating: D What is this?

  • +
  • CYTR
    Cytrx Cp
  • $0.55
  • -5.17%
  • $0.59

No Analysis added

People owning CYTR also tend to own: GNBTPLCACELAINVAMSWAEWZENCY

TheStreet.com Rating: D- What is this?

previous next
 

Start Price

Return Value

Start Date

ADLR 3.79 -19.26% May 17th
AEZS 3.57 -74.23% May 17th
AGEN 2.38 -26.05% May 17th
ARRY 12.71 -48.15% May 17th
BDSI 5.15 -30.10% May 17th
BUF 6.51 -78.19% May 17th
CEGE 3.92 -80.87% May 17th
CYTR 4.005 -86.27% May 17th
DNA 78.53 +23.06% May 17th
DNDN 5.99 -5.51% May 17th
ENCY 3.30 ------ May 17th
ENMD 1.69 -72.49% May 17th
EPCT 2.77 -77.62% May 17th
EXEL 11.06 -49.01% May 17th
GNBT 1.47 -55.78% May 17th
GNLB 1.86 -68.82% May 17th
GNVC 4.03 -67.99% May 17th
GTXI 18.13 +0.66% May 17th
HHJ 22.23 -31.57% May 17th
HHQ 27.46 -13.33% May 17th
IDMI 2.59 +16.99% May 17th
INGN 4.09 -90.22% May 17th
INSM 0.82 -33.07% May 17th
ISIS 9.86 +72.41% May 17th
MEDX 15.16 -54.95% May 17th
MYMX.PK 0.095 ------ May 17th
NEOL 1.48 -69.59% May 17th
NRMX 5.78 -65.40% May 17th
NUVO 3.46 -86.13% May 17th
NVAX 2.86 +1.05% May 17th
ONI 0.5099 +27.48% May 17th
SGMO 6.85 +39.12% May 17th
SPPI 6.28 -73.57% May 17th

Average return:

-35.83%

Success rate:

22.58%

Hated Stocks:

GTOP 3.64 ------ May 17th
IMGN 5.0301 +3.38% May 17th
NYMX 6.11 -8.35% May 17th

Tracking Started: 05-17-2007

Comments not available

ADD YOUR COMMENTS:

Barron's Roundup 9-6

Market’s Finest: Barron's asked professional investors who the world’s most respected companies are for its fourth annual survey. Some of the name that made the list in...

09.06.08 | 21:59 PM
Jim Cramer's Portfolios of the Week

Jim Cramer thinks market sentiment is starting to get extremely bearish, and it might be time for investors start looking at entry points in their favorite stocks. Despite ...

09.05.08 | 10:25 AM
Cramer's Take on Top-Searched St...

Disappointing economic news released on Thursday created a dismal atmosphere, with the Dow Jones plunging more than 300 points. Many of the nation's retailers said sho...

09.04.08 | 18:01 PM
Interview With Ken Fisher, Part VI

Good CEOs Vs. Bad CEOs By Stockpickr Guest Columnist Fred Fuld of Stockerblog.com Recently, I had the pleasure of interviewing Ken Fisher, head of the $30 billion F...

09.04.08 | 17:32 PM
more articles
Cramer cameos
09.05.08 | 23:56 PM From author Peter near Matanzas Inlet
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZackAttack
Reading charts
08.16.08 | 09:03 AM From author Peter near Matanzas Inlet
more forums
today 's lists
Stocks With Unusual Option Activity

Unusually active options can often indicate that a major event in a stock is about to take place, or that unsophisticated investors (using options in lieu of leverage) are ... more

Stocks Most Likely to Disappoint

This list consists of stocks that have had very nice up move over the last year and may be poised to disappoint going forward. The basis for the list is as follows: 52 w... more

52-Week Highs

Each day we'll select up to 10 stocks on the 52-week high list and give commentary. This is not a comprehensive list of the 52-week high list but just select stocks we thin... more